2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in characterization of solid renal masses

Molecular Imaging and Biology

Volumn 7, Issue 6, 2005, Pages 431-439

  Kumar, Rakesh ^a   Chauhan, Anil ^a   Lakhani, Paras ^b   Xiu, Yan ^b   Zhuang, Hongming ^b   Alavi, Abass ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b PENNSYLVANIA HOSPITAL   (United States)

Author keywords

F18 FDG PET; Renal cancer; Renal masses; Renal metastatic masses

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EXCRETION; DRUG UPTAKE; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; KIDNEY METASTASIS; KIDNEY TUMOR; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME; URINARY EXCRETION; METHODOLOGY; MIDDLE AGED; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 33644857682     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-005-0026-z     Document Type: Article

References (26)

1. Pantuck AJ, Zisman A, Belldegrun AS (2001) The changing natural history of renal cell carcinoma. J Urol 166:1611-1623
2. Newsam JE, Tulloch WS (1966) Metastatic tumours in the kidney. Br J Urol 38:1-6
3. Luciani LG, Cestari R, Tallarigo C (2000) Incidental renal cell carcinoma-age and stage characterisation and clinical implications: Study of 1092 patients (1982-1997). Urology 56:58-62
4. Mathew A, Devesa SS, Fraumeni JF Jr, Chow WH (2002) Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 11:171-178
5. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628-1631
6. Harisinghani MG, Maher MM, Gervais DA, et al. (2003) Incidence of malignancy in complex cystic renal masses (Bosniak category III): Should imaging-guided biopsy precede surgery? AJR Am J Roentgenol 180:755-758
7. Mickisch G, Carballido J, Hellsten S, Schulze H, Mensink H (2001) Guidelines on renal cell cancer. Eur Urol 40:252-255
8. Li G, Cuilleron M, Gentil-Perret A, Tostain J (2004) Characteristics of image-detected solid renal masses: Implication for optimal treatment. Int J Urol 11:63-67
9. Tello R, Davison BD, O'Malley M, et al. (2000) MR imaging of renal masses interpreted on CT to be suspicious. AJR Am J Roentgenol 174:1017-1022
10. Kumar R, Jana S (2004) Positron emission tomography: An advanced nuclear medicine imaging technique from research to clinical practice. Methods Enzymol 385:3-19
11. Hustinx R, Benard F, Alavi A (2002) Whole-body F18-FDG-PETimaging in the management of patients with cancer. Semin Nucl Med 32:35-46
12. Safaei A, Figlin R, Hoh CK, et al. (2002) The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol 57:56-62
13. Wahl RL, Harney J, Hutchins G, Grossman HB (1991) Imaging of renal cancer using positron emitting tomography with 2-deoxy-2-(18F)-fluoro-D-glucose: Pilot animal and human studies. J Urol 146:1470-1474
14. Kocher F, Geimmel S, Hauptmann R, Reske S (1994) Preoperative lymph node staging in patients with kidney and urinary bladder neoplasm. J Nucl Med 35(Suppl):223P [abstract]
15. Bachor R, Kotzerke J, Gottfried HW, Brandle E, Reske SN, Hautmann R (1996) Positron emission tomography in diagnosis of renal cell carcinoma. Urologe A 35:146-150
16. Goldberg MA, Mayo-Smith WW, Papanicolaou N, Fischman AJ, Lee MJ (1997) F18-FDG-PETcharacterisation of renal masses: Preliminary experience. Clin Radiol 52:510-515
17. Montravers F, Grahek D, Kerrou K, et al. (2000) Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera. J Nucl Med 41:78-84
18. Ramdave S, Thomas GW, Berlangieri SU, Bolton DM, Davis I, Danguy HT (2001) Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 166:825-830
19. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA (2004) The natural history of incidentally detected small renal masses. Cancer 100:738-745
20. Silverman SG, Lee BY, Seltzer SE, Bloom DA, Corless CL, Adams DF (1994) Small (< or = 3 cm) renal masses: Correlation of spiral CT features and pathologic findings. AJR Am J Roentgenol 163:597-605
21. Brierly RD, Thomas PJ, Harrison NW, Fletcher MS, Nawrocki JD, Ashton-Key M (2000) Evaluation of fine-needle aspiration cytology for renal masses. BJU Int 85:14-18
22. Scott AM, Larson SM (1993) Tumor imaging and therapy. Radiol Clin North Am 31:859-879
23. Aide N, Cappele O, Bottet P, et al. (2003) Efficiency of [18F]F18-FDG-PETin characterizing renal cancer and detecting distant metastases: A comparison with CT. Eur J Nucl Med 30:1236-1245
24. Miyauchi T, Brown RS, Grossman HB (1996) Correlation between visualization of primary renal cancer by F18-FDG-PETand histopathological findings. J Nucl Med 37(Suppl):64P [abstract]
25. Miyakita H, Tokunaga M, Onda H, Usui Y, Kinoshita H, Kawamura N, et al. (2002) Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol 9:15-18
26. Zhuang H, Pourdehnad M, Lambright ES, et al. (2001) Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42:1412-1417